Articles

WellPoint shares droop despite profitable quarter

WellPoint Inc.'s third-quarter earnings trumped Wall Street expectations, but the health insurer's stock tumbled Wednesday after President Barack Obama won re-election, a victory that could help cement the future of his health care overhaul.

Read More

Community to commercialize innovations

Community Health Network thinks it can help patients, engage doctors and maybe even make some money by trying to turn ideas within its organization into commercial products, service and companies.

Read More

Low enrollment clouds Healthy Indiana Plan

Many Indiana Republicans want to use the Healthy Indiana Plan to expand Medicaid coverage in Indiana to more low-income adults. But the program—which offers health insurance based on health savings accounts to uninsured adults—has managed to attract just one-third of the Hoosiers it was designed for and has cost about twice as much per enrollee as predicted.

Read More

Outlook gloomy for device investments

The amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association and PricewaterhouseCoopers.

Read More

Lilly’s insulin dip concerns analysts

Eli Lilly and Co. suffered a tough week on the stock market, in part because of a disturbing bit of news buried in its third-quarter earnings report: Lilly’s insulin sales are down.

Read More

Judge approves $90 million for Anthem plaintiffs

The settlement will go to 700,000 claimants in Indiana, Ohio, Kentucky and Connecticut, who said Anthem underpaid them when it converted in 2001 from policyholder ownership into publicly traded company WellPoint Inc.

Read More

Amerigroup shareholders approve $4.9B sale to WellPoint

Shareholders of Amerigroup Corp. overwhelming approved the Virginia company’s sale for $4.9 billion to Indianapolis-based health insurer WellPoint Inc. in a vote on Tuesday. The vote clears the way for the acquisition to close before the end of the year.

Read More

Lilly CEO calls for life sciences research institute

Eli Lilly CEO John Lechleiter on Tuesday called for creation of a “world-class” research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.

Read More